Global Giant Cell Arteritis Treatment Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 15906

Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin however, current evidences are mixed. In a large epidemiologic study with a 12-year follow-up, there has been synchronous variation in the incidence of giant cell arteritis with epidemics of Mycoplasma pneumoniae, Chlamydia pneumonia and parvovirus B19.
Giant cell arteritis is a disease that affects twice as many females than males. Giant cell arteritis is estimated to affect 120,000 individuals in the United States. The incidence of GCA in Saudi Arabia is probably less than in the United States and Western Europe.
In 2018, the global Giant Cell Arteritis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Giant Cell Arteritis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Giant Cell Arteritis Treatment development in United States, Europe and China.

The key players covered in this study
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
...

Market segment by Type, the product can be split into
Corticosteroid Therapy
Adjuvant Agents

Market segment by Application, split into
Hospitals
Clinics
ASC’s
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Giant Cell Arteritis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Giant Cell Arteritis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Giant Cell Arteritis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Corticosteroid Therapy
1.4.3 Adjuvant Agents
1.5 Market by Application
1.5.1 Global Giant Cell Arteritis Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 ASC’s
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Giant Cell Arteritis Treatment Market Size
2.2 Giant Cell Arteritis Treatment Growth Trends by Regions
2.2.1 Giant Cell Arteritis Treatment Market Size by Regions (2014-2025)
2.2.2 Giant Cell Arteritis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Giant Cell Arteritis Treatment Market Size by Manufacturers
3.1.1 Global Giant Cell Arteritis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Giant Cell Arteritis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Giant Cell Arteritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Giant Cell Arteritis Treatment Key Players Head office and Area Served
3.3 Key Players Giant Cell Arteritis Treatment Product/Solution/Service
3.4 Date of Enter into Giant Cell Arteritis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Giant Cell Arteritis Treatment Market Size by Type (2014-2019)
4.2 Global Giant Cell Arteritis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Giant Cell Arteritis Treatment Market Size (2014-2019)
5.2 Giant Cell Arteritis Treatment Key Players in United States
5.3 United States Giant Cell Arteritis Treatment Market Size by Type
5.4 United States Giant Cell Arteritis Treatment Market Size by Application

6 Europe
6.1 Europe Giant Cell Arteritis Treatment Market Size (2014-2019)
6.2 Giant Cell Arteritis Treatment Key Players in Europe
6.3 Europe Giant Cell Arteritis Treatment Market Size by Type
6.4 Europe Giant Cell Arteritis Treatment Market Size by Application

7 China
7.1 China Giant Cell Arteritis Treatment Market Size (2014-2019)
7.2 Giant Cell Arteritis Treatment Key Players in China
7.3 China Giant Cell Arteritis Treatment Market Size by Type
7.4 China Giant Cell Arteritis Treatment Market Size by Application

8 Japan
8.1 Japan Giant Cell Arteritis Treatment Market Size (2014-2019)
8.2 Giant Cell Arteritis Treatment Key Players in Japan
8.3 Japan Giant Cell Arteritis Treatment Market Size by Type
8.4 Japan Giant Cell Arteritis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Giant Cell Arteritis Treatment Market Size (2014-2019)
9.2 Giant Cell Arteritis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Giant Cell Arteritis Treatment Market Size by Type
9.4 Southeast Asia Giant Cell Arteritis Treatment Market Size by Application

10 India
10.1 India Giant Cell Arteritis Treatment Market Size (2014-2019)
10.2 Giant Cell Arteritis Treatment Key Players in India
10.3 India Giant Cell Arteritis Treatment Market Size by Type
10.4 India Giant Cell Arteritis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Giant Cell Arteritis Treatment Market Size (2014-2019)
11.2 Giant Cell Arteritis Treatment Key Players in Central & South America
11.3 Central & South America Giant Cell Arteritis Treatment Market Size by Type
11.4 Central & South America Giant Cell Arteritis Treatment Market Size by Application

12 International Players Profiles
12.1 Johns Hopkins Hospital
12.1.1 Johns Hopkins Hospital Company Details
12.1.2 Company Description and Business Overview
12.1.3 Giant Cell Arteritis Treatment Introduction
12.1.4 Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2014-2019)
12.1.5 Johns Hopkins Hospital Recent Development
12.2 Fortis Healthcare
12.2.1 Fortis Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Giant Cell Arteritis Treatment Introduction
12.2.4 Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2014-2019)
12.2.5 Fortis Healthcare Recent Development
12.3 American College of Rheumatology
12.3.1 American College of Rheumatology Company Details
12.3.2 Company Description and Business Overview
12.3.3 Giant Cell Arteritis Treatment Introduction
12.3.4 American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2014-2019)
12.3.5 American College of Rheumatology Recent Development
12.4 Duke University Health System
12.4.1 Duke University Health System Company Details
12.4.2 Company Description and Business Overview
12.4.3 Giant Cell Arteritis Treatment Introduction
12.4.4 Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2014-2019)
12.4.5 Duke University Health System Recent Development
12.5 Lahey Clinic Foundation
12.5.1 Lahey Clinic Foundation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Giant Cell Arteritis Treatment Introduction
12.5.4 Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2014-2019)
12.5.5 Lahey Clinic Foundation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details